Skip to main content
War in Gaza:: find out how we're responding
Learn more
7467 Results
 
Diagnosing, treating and researching HIV-kala azar co-infection
Kala azar

Diagnosing, treating and researching HIV-kala azar co-infection in Ethiopia

MSF teams in Abdurafi, Ethiopia, talk about the challenges of diagnosing and treating kala azar in people living with HIV, and are collaborating on research into ways to better understand and prevent the neglected tropical disease. Project Update - 20 Sep 2018
 
Snakebite Amputation
Snakebite

Time to strike back at snakebite and end the antivenom access crisis

Every year, an estimated 2.7 million people are bitten by venomous snakes, resulting in death for more than 100,000 people. Although effective treatment exists for snakebite envenoming, the vast majority of people aren’t able to access it. Report - 19 Sep 2018
 
msf-placeholder
About MSF

Five myths about working for MSF

blogs.msf.org - 18 Sep 2018
 
Consequences of war for civilian population in Bangassou
Central African Republic

“We simply can’t let these people down. But we remain vigilant”: MSF returns to Bangassou

In 2017 a series of security incidents forced MSF to evacuate our team from Bangassou, CAR, and suspend activities in the area. In April 2018, our team returned to the city. Interview - 18 Sep 2018
 
Trapped in Moria
Greece

Moria is in a state of emergency

An open letter from MSF clinical psychiatrist Dr Alessandro Barberio, Moria camp, Lesbos, Greece on the desperate circumstances for refugees in the camp and the mental health emergency Open Letter - 17 Sep 2018
 
Trapped in Moria
Greece

Self-harm and attempted suicides increasing for child refugees in Lesbos

MSF teams seeing increasing levels of suicide attempts and self-harm among child refugees on Lesbos, urge Greece and the EU to evacuate vulnerable refugees.

Press Release - 17 Sep 2018
 
TB treatments yield promising results in the Chechen Republic
Tuberculosis

Open Letter to J&J: Calling for affordable access to critical TB drug bedaquiline

MSF sent an open letter to Johnson & Johnson urging the pharmaceutical corporation to take action so that countries can access an affordable and sustainable supply of the critical drug bedaquiline, used to treat multidrug-resistant tuberculosis (MDR-TB). msfaccess.org - 17 Sep 2018
 
MSF protest against sofosbuvir patent in Munich
Hepatitis C

MSF response to ruling in Gilead sofosbuvir patent hearing at European Patent Office

Médecins Sans Frontières (MSF) is gravely disappointed with the European Patent Office’s decision today to uphold US pharmaceutical corporation Gilead Sciences’ patent related to the key hepatitis C drug sofosbuvir. Access Campaign - 14 Sep 2018
 
Physiotherapy at SICA hospital, Bangui
Central African Republic

Restoring body and mind through physiotherapy

Photo Story - 14 Sep 2018
 
Ebola outbreak in Magina
DRC Ebola outbreaks

With a new Ebola outbreak, we knew we had to act fast

An experienced nurse, Patient Muhindo Kamavu was one of four MSF nurses who were the first on the ground, alongside the Ministry of Health, to respond to the Ebola outbreak declared on 1 August in Mangina, North Kivu, Democratic Republic of Congo. Voices from the Field - 13 Sep 2018
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more